SNCA and Parkinson disease: Alpha-synuclein seeding assays in CSF or tissues like skin or olfactory mucosa have shown very promising diagnostic performance in PD and also prodromal cohorts with idiopathic RBD [57, 58, 62], but so far they have not been tested or validated regarding their sensitivity to measure disease progression.